When is Benzene testing required under the Generic Remedy?

Benzene testing is required under the Generic Remedy when the concentration exceeds 2,500 parts per million (ppm). This threshold is established to ensure that any potential contamination with benzene, a known carcinogen, is identified and properly managed. The requirement for testing at 2,500 ppm is based on the potential health risks associated with exposure to benzene at higher concentrations, as well as regulatory frameworks that aim to protect public health and the environment.

By setting this specific concentration level for testing, regulators can ensure that contaminated sites receive appropriate evaluation and remediation, thus minimizing any adverse effects on human health and ecosystems. This standard reflects ongoing concerns about the dangers of benzene and emphasizes the importance of early detection of hazardous substances in the context of environmental safety and compliance with health regulations.